HIV Disclosure and Medication Adherence, a Pilot Study

Completed

• Conditions: HIV Infection

• Registration Number: NCT01621412
• Lead Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Brief Summary

The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Detailed Description

Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.

Adherence is measured by electronic monitoring and pill count.

Study Timeline

• Study Start: 2012-04
• Study First Submitted: 2012-05-31
• Study First Submitted QC: 2012-06-13
• Study First Posted: 2012-06-18
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Status Verified: 2015-12
• Last Update Submitted: 2015-12-21
• Last Update Posted: 2015-12-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• HIV Infection
• Enrolled in the adherence-enhancing program

Exclusion Criteria

• Inclusion visit
• Not french or english speaker

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Adherence	30 days before survey	Electronic monitoring of adherence during 30 days before survey

Secondary Outcome Measures

Name	Time	Method
Patient Adherence	90 days before survey	Electronic monitoring of adherence during 90 days before survey

Trial Locations

Locations (1)

Policlinique Médicale Universitaire; 🇨🇭 Lausanne, Vaud, Switzerland